Evaluating the safety and rationale for cinacalcet posttransplant hyperparathyroidism and hypercalcemia

D. W. Coyne; R. Delos Santos

doi:10.1111/ajt.12913

Evaluating the safety and rationale for cinacalcet posttransplant hyperparathyroidism and hypercalcemia

D. W. Coyne
, R. Delos Santos

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	2446-2447
Number of pages	2
Journal	American Journal of Transplantation
Volume	14
Issue number	11
DOIs	https://doi.org/10.1111/ajt.12913
State	Published - Nov 1 2014

Access to Document

10.1111/ajt.12913

Cite this

@article{84bf619539674fe3af864e9544927136,

title = "Evaluating the safety and rationale for cinacalcet posttransplant hyperparathyroidism and hypercalcemia",

author = "Coyne, \{D. W.\} and Santos, \{R. Delos\}",

note = "Funding Information: The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. DWC is a consultant to Keryx, Rockwell, Hospira, Fresenius, and a speaker for Abbvie, and has been or is involved in suits related to the overuse and abuse of ESAs, IV iron and IV Vitamin D in dialysis patients. RDS has participated in an advisory board for Amgen.",

year = "2014",

month = nov,

day = "1",

doi = "10.1111/ajt.12913",

language = "English",

volume = "14",

pages = "2446--2447",

journal = "American Journal of Transplantation",

issn = "1600-6135",

number = "11",

}

TY - JOUR

T1 - Evaluating the safety and rationale for cinacalcet posttransplant hyperparathyroidism and hypercalcemia

AU - Coyne, D. W.

AU - Santos, R. Delos

N1 - Funding Information: The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. DWC is a consultant to Keryx, Rockwell, Hospira, Fresenius, and a speaker for Abbvie, and has been or is involved in suits related to the overuse and abuse of ESAs, IV iron and IV Vitamin D in dialysis patients. RDS has participated in an advisory board for Amgen.

PY - 2014/11/1

Y1 - 2014/11/1

UR - https://www.scopus.com/pages/publications/84911987315

U2 - 10.1111/ajt.12913

DO - 10.1111/ajt.12913

M3 - Editorial

C2 - 25223316

AN - SCOPUS:84911987315

SN - 1600-6135

VL - 14

SP - 2446

EP - 2447

JO - American Journal of Transplantation

JF - American Journal of Transplantation

IS - 11

ER -

Evaluating the safety and rationale for cinacalcet posttransplant hyperparathyroidism and hypercalcemia

Access to Document

Other files and links

Cite this